Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Short-term Investments (2016 - 2025)

Lipocine (LPCN) has disclosed Short-term Investments for 10 consecutive years, with $11.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-term Investments fell 30.16% year-over-year to $11.2 million, compared with a TTM value of $11.2 million through Sep 2025, down 30.16%, and an annual FY2024 reading of $15.4 million, down 10.64% over the prior year.
  • Short-term Investments was $11.2 million for Q3 2025 at Lipocine, down from $11.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $41.7 million in Q4 2021 and bottomed at $11.2 million in Q3 2025.
  • Average Short-term Investments over 5 years is $24.3 million, with a median of $21.6 million recorded in 2024.
  • The sharpest move saw Short-term Investments surged 9159.59% in 2021, then tumbled 41.24% in 2023.
  • Year by year, Short-term Investments stood at $41.7 million in 2021, then fell by 29.49% to $29.4 million in 2022, then crashed by 41.24% to $17.3 million in 2023, then fell by 10.64% to $15.4 million in 2024, then decreased by 27.21% to $11.2 million in 2025.
  • Business Quant data shows Short-term Investments for LPCN at $11.2 million in Q3 2025, $11.9 million in Q2 2025, and $16.4 million in Q1 2025.